Post hoc longitudinal assessment of the efficacy and safety of recombinant factor IX Fc fusion protein in hemophilia B

A ShapiroR KulkarniM RagniH ChambostJohnny MahlanguE et al2024-07-232024-07-23WOS2473-9529https://hdl.handle.net/10539/39018Post hoc longitudinal assessment of the efficacy and safety of recombinant factor IX Fc fusion protein in hemophilia BJournal Article